This medication requires a valid prescription. Please refer to the ‘Prescription Guide’ for details.
Note: We can assist only if the medicine is unavailable in your country.”
Shipping:
Room Temperature Shipping
Fotivda (tivozanib) is shipped under standard controlled room temperature conditions (15°C to 25°C). Specialized medical couriers ensure product integrity during transit, maintaining consistent temperature and handling standards to deliver the medicine safely and effectively.
Disease Indication:
• Advanced Renal Cell Carcinoma (RCC)
Manufacturer:
EUSA Pharma
Usage:
Oral
Fotivda (tivozanib)
General Description:
Fotivda (tivozanib) is a prescription oral therapy used for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) who have received two or more prior systemic therapies. It works by inhibiting vascular endothelial growth factor receptors (VEGFR), which play a key role in tumor angiogenesis — the process by which cancer cells form new blood vessels. By blocking this pathway, Fotivda helps slow tumor growth and disease progression in patients with advanced kidney cancer.
Fotivda is taken orally under the supervision of a qualified oncologist. Your doctor will determine the dosage and treatment schedule based on your specific medical condition and response to therapy.
Getting Fotivda (tivozanib) in India
Fotivda is approved by major global regulatory authorities, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Although it may not yet be widely available in India, eligible patients can access Fotivda through a Named Patient Program (NPP) under physician guidance.
MitoGENE supports Indian patients in obtaining Fotivda safely and compliantly. Our expert team manages all documentation, import permits, and logistics in accordance with India’s regulatory requirements. We ensure a secure, transparent, and patient-centric process to help you or your loved one access Fotivda (tivozanib) for advanced renal cell carcinoma (RCC).
Medicine Approved By:
• Food and Drug Administration (FDA)
• European Medicines Agency (EMA)
Available Dosage Form & Package:
• Capsules – 21 capsules of 1340 mcg each
How to Access Fotivda (tivozanib) in India in 4 Simple Steps with MitoGENE via the Named Patient Program (NPP)?
If Fotivda (tivozanib) is not yet approved or commercially available in India, MitoGENE can assist you in accessing it legally through the Named Patient Program (NPP). Here’s how the process works:
